Rakesh Jain - Tekla Life Insider

XHQLX -- USA Fund  

USD 20.98  0.03  0.14%

  Executive
Dr. Rakesh K. Jain, Ph.D. is Independent Trustee of HQ Life Sciences Investors. Dr. Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing each Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain cofounded XTuit Pharmaceuticals, Inc. in 2011, where he also serves as a board member. He serves on the Governance and Nominating Committee of each Fund. Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than 600 publications. He serves on advisory panels to government, industry and academia, and has served or continues to serve on editorial advisory boards of twenty journals, including Journal of Clinical Oncology and Nature Reviews Clinical Oncology. He has received more than 70 major awards and lectureships, including a Guggenheim Fellowship, the Humboldt Senior Scientist Award, the National Cancer Institute Research Career Development Award and Outstanding Investigator Grant, the Academic Scientist of the Year Award from the Pharmaceutical Achievements Awards, the Distinguished Service Award from Nature Biotechnology and the Innovator Award from the DoD Breast Cancer Program. He is a member of all three branches of US National Academies the Institute of Medicine, the National Academy of Engineering and the National Academy of Sciences and is a member of the American Academy of Arts and Sciences.
Age: 66  Executive Since 2007      

Management Performance (%)

Similar Money Managers

Found 11 records

One Year Return

Barbara MillerJPMorgan Core Bond R4
0.0%
Bob MillerBlackRock Strategic Income Opps
0.0%
Carl EichstaedtWestern Asset Core Plus Bond FI
6.37%
Carl EichstaedtWestern Asset Core Plus Bond I
7.65%
Dina PerryAmerican Funds Fundamental Invs
-1.05%
Andrew OBrienLord Abbett Short Duration Inco
0.0%
Mark DenningAmerican Funds SMALLCAP World R
-5.55%
James LovelaceAmerican Funds Capital Income B
3.44%
Rick RiederBlackRock Strategic Income Opps
0.0%
Barbara MillerJPMorgan Core Bond I
8.05%
Daniel ShackelfordT Rowe Price New Income R
5.57%

Fund Summary

The fund is listed under null category and is part of null family.

Tekla Life Sciences Leadership Team

William Reardon, Independent Trustee
Michael Bonney, Independent Trustee
Oleg Pohotsky, Independent Trustee
Lucinda Stebbins, Independent Trustee
Daniel Omstead, President Trustee
Uwe Reinhardt, Independent Trustee
Rakesh Jain, Independent Trustee

Fund Performance Indicators

Did you try this?

Run Cryptocurrency Correlation Now
   

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
All  Next Launch Cryptocurrency Correlation

Also Currentnly Active

Purchased over 20 shares of
few hours ago
Traded for 106.27
Purchased over 200 shares of
few hours ago
Traded for 10.56
Purchased over 70 shares of
few hours ago
Traded for 39.4
See also Your Current Watchlist. Please also try Coins and Tokens Correlation module to utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">